Diabetes Management Market By Device Type, (Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices), By Therapeutics, (Injectable, Oral Drugs), Industry analysis, Trends, Estimation & forecast, 2016 - 2024
This report studies Diabetes Management in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2025.
The term diabetes is referred to a disease which reduces the capability of the body to produce or respond to the hormone insulin, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood. Scientifically, diabetes is also known as mellitus, and is classified as disorganization of pancreases to produce insulin (Type I) and unresponsiveness of body cells to the produced insulin (Type II) or both. This illness specifically results in increase in thrust and hunger. The cases of type II diabetes are majorly witnessed all around the world as a result of increased obesity, urbanization, poor diet and substandard healthcare conditions. The main goal of diabetes management is, as soon as possible, to restore carbohydrate metabolism to a normal state. The global market for diabetes is extremely profitable for drug and device manufacturers as treatment majorly demands therapeutic and diagnostic management.
Diabetes Management Market Determinants
The key factor driving the growth of global diabetes management market is the increasing diabetic patients and increasing healthcare awareness. As per the data revealed by National Diabetes Statistics Report, in 2015, an estimated 23.1 million people, or 7.2% of the U.S. population had diagnosed diabetes. Moreover, increase in collaborations & associations are creating better avenues to attain high effectiveness. In addition to this, increasing occurrence of type I and type II diabetes as a result of high obese population is highly stimulating the market growth. However, high costs related to diabetes management, limited infrastructure for management and counterfeiting of drugs are major restraining factors for global diabetes management market. On the other hand, developing economies are expected to provide huge growth potential for the market, during the few years.
Diabetes Management Market Segmentation
• By Device Type
o Monitoring Devices
o Blood Glucose Meters
o Blood Sampling Devices
o Diagnostic Devices
o Hemoglobin A1c
o Hemoglobin A1c Kits
o Hemoglobin A1c Meters
o Insulin Delivery Devices
o Insulin Pumps
o Insulin Pens
o Disposable Insulin Pens
o Insulin Syringes
o Reusable Insulin Pens
o Others (artificial pancreas, artificial pancreas, commercial software)
• By Therapeutics
o Oral Drugs
o Alpha-Glucosidase Inhibitors
o Dipeptidyl Inhibitors
o Combination Medications
• By Geography
o North America
o Rest of World
Table of Content
• Abbott Laboratories
• Novo Nordisk A/S
• Bristol-Myers Squibb
• Eli Lilly and Co.
• Bayer AG
What Information does this report contain?
• What was the market size of the Diabetes Management Market in 2016 and the expected market size by 2024, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions, and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2016 – 2024)?
• Which are the leading companies in the Diabetes Management Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?
You may also like
Medical Textiles Market by Fabric (Woven, Knitted, Non-Woven, and Others); By Application (Implantable Goods, Non-Implantable Goods, Healthcare & Hygiene Products, and Others); By Geography (North America, Asia-Pacific, Europe, South America, and RoW), Industry Trends, Estimation & Forecast, 2018 – 2026
Blood Preparation Market by Product (Whole Blood, Blood Components, and Blood Derivatives); By Type (Platelet Aggregation Inhibitors, Fibrinolytics, and Anticoagulants); By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, and Others); By Geography (North America, Asia-Pacific, Europe, South America, and RoW), Industry Trends, Estimation & Forecast, 2018 – 2026